✦ LIBER ✦

MP-18.09: A Clinical Study of Carboplatin plus Docetaxel in Patients with Metastatic Hormone-Refractory Prostate Cancer

✍ Scribed by I. Go; T. Ito; K. Kuratsukuri; M. Matsuyama; S. Tamada; T. Tanaka; J. Uchida; R. Yoshimura; H. Kawashima; T. Nakatani

Book ID: 116951265
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 151 KB
Volume: 74
Category: Article
ISSN: 0090-4295
DOI: 10.1016/j.urology.2009.07.1344

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase 2 study of carboplatin plus doce

A phase 2 study of carboplatin plus docetaxel in men with metastatic hormone-refractory prostate cancer who are refractory to docetaxel

✍ Robert W. Ross; Tomasz M. Beer; Susanna Jacobus; Glenn J. Bubley; Mary-Ellen Tap 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB 👁 2 views

## Abstract ## BACKGROUND. Prostate cancer is the second leading cause of cancer mortality among men in the U.S. To the authors' knowledge, there is no proven, effective, second‐line therapy for docetaxel‐refractory disease. Recent data suggest that platinum salts may be effective when combined wi

Three Weekly Docetaxel plus Predinsolone

Three Weekly Docetaxel plus Predinsolone for Patients with Hormone-Refractory Metastatic Prostate Cancer: Preliminary Result

✍ Abd El Halim M. Abu-Hamar; Saleh Mansour; Mohamed M. El Shebiney; Naser M. Abd E 📂 Article 📅 2010 🏛 Dougmar Publishing Group, Inc. 🌐 English ⚖ 89 KB

Phase-II Study of Docetaxel, Estramustin

Phase-II Study of Docetaxel, Estramustine Phosphate, and Carboplatin in Patients with Hormone-Refractory Prostate Cancer

✍ Nobuyuki Kikuno; Shinji Urakami; Shigeru Nakamura; Takeo Hiraoka; Taijyu Hyuga; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 176 KB

Evaluation of docetaxel plus estramustin

Evaluation of docetaxel plus estramustine in the treatment of patients with hormone-refractory prostate cancer

✍ Akihiro Matsumoto; Atsushi Inoue; Satoshi Yokoi; Kazuyoshi Nozumi; Kanetaka Miya 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB

Response to docetaxel/carboplatin-based

Response to docetaxel/carboplatin-based chemotherapy as first- and second-line therapy in patients with metastatic hormone-refractory prostate cancer

✍ Mari Nakabayashi; Oliver Sartor; Susanna Jacobus; Meredith M. Regan; David McKea 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB

MP-08.08: Docetaxel-prednisolone combina

MP-08.08: Docetaxel-prednisolone combination therapy for japanese patients with hormone-refractory prostate cancer: a phase 2 study

✍ N. Miura; K. Numata; A. Shirato; K. Hashine; Y. Sumiyoshi 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 60 KB